Adult Type 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D
New rapid acting meal time Insulin to treat Type 2 Diabetes
Study Length: 39 Weeks
Target Age/Sex: 18+, Male and Female
Participants will receive at no cost: Study medication, study related supplies, study related lab work and medical exams. Subject will also receive a stipend for time/travel related to the study.